Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way ...

Hims & Hers releases Super Bowl ad criticizing pharmaceutical industry and weight loss market, promoting their compounded GLP ...

A Super Bowl ad for weight loss medications from telehealth company Hims & Hers is optimized to engage and infuriate ...

Hims & Hers, a tele-health start-up, aims to stand apart from dozens of Super Bowl commercials hawking snacks with a spot ...

Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced ...

Losing weight can feel like climbing a mountain with no clear path. The one-size-fits-all advice—like “eat less, move ...

The UK should negotiate a new customs union deal with the European Union, Liberal Democrat leader Sir Ed Davey has said. In a speech in London, he argued it was needed to boost Britain's economy ...

Hims & Hers Health (NYSE: HIMS) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. Is Hims & Hers stock in trouble, or is this just a bump in the road for what could still ...

In emphasizing loyalty as he selects his team for a second administration, President-elect Donald Trump often has overlooked another quality typically required for such jobs: High-level experience.

But for Hims & Hers, offering such drugs has opened up a potential ... via a telehealth service to help treat areas such as erectile dysfunction and hair loss, which are key areas that Hims ...